Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy

AI Briefing

• – Neurogene to Present on ICV Delivery in CNS-Targeted Gene Therapy
• – Company aims to demystify ICV route as a well-established neurosurgical procedure
• – ICV delivery strategy designed to maximize efficacy for CNS gene therapy